Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Hematologic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3beta-Thalassemia 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Graft vs Host Disease 2Anemia, Refractory, with Excess of Blasts 2Virus Diseases 1Thalassemia 1Primary Myelofibrosis 1Non-Malignant Neoplasm 1Neurofibromatosis 1 1Neoplasm, Residual 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, B-Cell 1Influenza, Human 1Fanconi Anemia 1Cytopenia 1Chromosome Aberrations 1Chromosome 7, monosomy 1Anemia, Sickle Cell 1

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Reverse Transcriptase Polymerase Chain Reaction 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1Bronchoalveolar Lavage 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chromosome Aberrations × thymoglobulin × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡